Pfizer strikes global licensing deal for Covid pill
GENEVA: US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if the promising pill passes trials and regulatory approval. Pfizer, which also produces a Covid vaccine with German lab BioNTech, said it had signed an agreement to sub-licence production of its Paxlovid pill to … Read more
